The true understanding of ageing and disc degeneration (DD) is still elusive. MRI has not helped our attempts to understand the health and disease status of the discs as it reflects mainly the end morphological changes and not the changes at molecular level. Understanding degeneration at molecular level through proteomics will allow differentiation from normal ageing and also aid in the development of biomarkers for early diagnosis and preventive therapies